| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_164d397287ae6f0cbaf2c140c0c8cd00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca658ca6dde6dd7c8b2524e6c8601a84 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 |
| filingDate |
2010-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_084c7b8591d3747b225daaf0b533f095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a7ece4eefa954715b23a515216bbac8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_020efdb6831c24d62a4aafbc260c8d6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_800473f15d32ef4ea0e46473985ebcd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_393c2c8c219b3e4f3b93de763a1f7e1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61143d535dcec5a26d48223230d6363e |
| publicationDate |
2012-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20120055313-A |
| titleOfInvention |
Sustained-release pharmaceutical composition with improved elution stability, including levetiracetam or a pharmaceutically acceptable salt thereof and method for preparing same |
| abstract |
The present invention relates to a sustained-release pharmaceutical composition comprising levetiracetam or a pharmaceutically acceptable salt thereof and a method for preparing the same, and more particularly, no significant change in dissolution rate under various dissolution conditions, thereby greatly improving dissolution stability. A sustained release pharmaceutical composition comprising tyracetam or a pharmaceutically acceptable salt thereof and an improved method for preparing the pharmaceutical composition in a simple and easy process. |
| priorityDate |
2010-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |